Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Visiongain Reports | The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008

The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008

The major problem facing the Wholesale & Distribution industry is its low profit margin which is in the region of only 1-2%. However, this market is entering into a crucial period with many key products losing patent protection, facing heavy generic competition. As generics are priced lower than their branded counterparts, the actual dollar profit on them taken by W&D companies, for their movement, is reduced. In the light of this, other key factors such as new pricing and distribution models are also discussed in more detail. Other important issues that are affecting the industry and discussed in detail include:

1. Drug Counterfeiting

2. Direct-to-Pharmacy Distribution

3. Parallel Trade

4. Canada and US Drug Reimportation

5. Internet drugs: Mail Order and On-line Pharmacies.

The objectives of this report are to understand the W&D industry, why it occurs, who it affects, different natures of wholesale-distribution and what kinds of strategies are involved. Wholesale-Distribution has both pros and cons for different healthcare stakeholders. Wholesale-Distribution is a complex area, where there are many “grey” areas.

In particular, The Pharmaceutical Wholesale and Distribution Sector concentrates on the following essential aspects of the industry:

• Discussion of the current W&D market

• Forecast of the big three US wholesalers from 2008-2013

• Drivers and restraints facing the W&D market

• Opportunities and threats facing the W&D market

• Commercial prospects for the W&D market

• Discussion of unmet needs

This report examines the industry critically through a comprehensive review of available information, including that from commercial databases and other highly relevant sources, including SWOT analysis. Visiongain applies financial forecasting, qualitative analyses and the assessment of unmet needs to provide a comprehensive market report with detailed analysis and informed opinion.

Why you should buy this report:

• To receive a comprehensive analysis of the prospects for the W&D market

• To discover predicted revenues, growth rates and other key metrics for the big three US wholesalers from 2008-2013

• To determine key activities of leading pharmaceutical manufacturers

• To determine the forces that influence the W&D market

• Competitive characteristics of the market

• Drivers

• Restraints

• Strengths, weaknesses, opportunities and threats (SWOT analysis)

• To find out where the W&D industry is heading - both technologically and commercially

Pricing:

Single user - password protected costs $2995.00

Departmental copies (this entitles up to 5 individual users in your department) of this report are available for only

USD 5995. This is not suitable for library usage.

Allow your whole company to have access to this information for only USD 9,995. Company-wide License allows your whole company access and intranet use on CD Rom and .pdf. Suitable for library storage and use.

Does your company have over 2,500 employees? Have the whole company access this information for a special rate of only USD 13,995

Publication date: 2-6-08

Number of pages in report: 136

Format: PDF
Table of Contents
Sample Page

License

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions